Squamous cell carcinoma of the larynx is rarely encountered in HIV (human immunodeficiency virus)-positive patients compared with HIV-associated malignancies. Standard protocols are absent for the management of laryngeal carcinoma in HIV-positive patients. HIV infection-associated immune suppression increases the mortality and morbidity of laryngeal carcinoma treatment.
View Article and Find Full Text PDF